United Therapeutics Corporation UTHR

475.45 3.24 0.69% as of 25 Sep
Market cap
$20.3B
P/E
15.7×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
8.89 15.88 8.01 0.00 13.03 20.40 17.07 10.80 13.34 16.14
P/S ratio
3.94 3.87 2.91 2.66 4.52 5.76 6.42 4.57 5.54 6.78
P/FCF ratio
10.50 17.10 8.05 0.00 9.67 20.55 18.89 14.33 14.83 20.85
P/Operating CF
38.60 (77.92) 55.47 37.64 53.16 55.57 97.01 70.60 46.74 62.35
P/B ratio
3.41 3.18 1.70 1.39 1.98 2.45 2.59 1.78 2.47 3.04
Price to Tangible BV
3.47 3.25 1.81 1.47 2.07 2.48 2.62 1.81 2.52 3.09
EV/Sales
3.29 3.63 2.35 2.22 3.99 5.23 5.50 3.59 4.55 5.96
EV/EBITDA
4.81 7.40 4.54 0.00 9.21 14.56 10.33 6.74 9.02 12.02
EV/Operating CF
8.17 13.20 4.91 (15.60) 7.84 14.75 13.27 8.53 9.86 12.15
EV/FCF
8.76 16.01 6.49 (10.90) 8.54 18.68 16.17 11.24 12.16 18.32
Quick Ratio
3.81 2.75 5.75 3.54 6.16 6.97 8.91 4.07 4.80 5.83
Current Ratio
4.29 3.26 6.39 4.03 6.70 7.61 9.85 4.41 5.25 6.60
Net Debt/EBITDA
(0.96) (0.80) (1.39) 4.49 (1.61) (1.87) (1.98) (1.85) (2.05) (1.85)
Debt/Assets
0.00% 8.68% 7.35% 21.72% 17.33% 15.48% 13.24% 9.77% 4.07% 0.00%
Debt/Equity
0.00 0.12 0.09 0.31 0.24 0.20 0.17 0.12 0.05 0.00
Asset Turnover
0.71 0.66 0.52 0.40 0.35 0.34 0.35 0.35 0.40 0.42
Operating CF/Net income
0.90 1.13 1.32 1.98 1.47 1.26 1.10 0.99 1.11 1.17
Capex/Depreciation
(1.20) (2.52) (5.14) (1.82) (1.14) (2.42) (2.71) (4.33) (3.40) (6.14)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
41.50% 21.14% 24.10% (3.75%) 16.67% 12.94% 16.61% 18.27% 19.23% 19.71%
ROA
31.65% 16.06% 18.76% (2.86%) 12.07% 9.73% 12.97% 14.91% 16.45% 17.51%
ROIC
82.89% 35.76% 31.02% (5.47%) 15.72% 12.28% 22.20% 20.07% 24.75% 22.34%
Return on Tangible Assets
45.13% 26.98% 26.89% (4.88%) 19.99% 17.00% 18.66% 25.97% 27.42% 27.40%
Average Days of Receivables
48.97 62.85 39.40 38.14 38.73 43.03 41.55 43.74 35.43 40.16
Research and Development Expense of Revenue
9.23% 15.34% 21.99% 81.63% 24.12% 32.04% 16.68% 17.53% 16.72% 17.28%
Selling, General and Administrative Expense of Revenue
19.81% 19.13% 16.33% 23.21% 28.58% 27.71% 24.90% 20.50% 24.66% 23.75%
Intangible Assets out of Total Assets
0.01 0.02 0.05 0.04 0.03 0.01 0.01 0.02 0.02 0.01
Share Based Compensation of Revenue
0.76% 4.26% (1.62%) 3.13% 11.04% 8.22% 5.52% 1.68% 5.00% 4.64%
Graham Net Nets
0.15 0.10 0.24 0.19 0.14 0.11 0.17 0.22 0.19 0.14
Graham Number
124.12 101.42 140.06 0.00 141.90 144.95 194.87 246.16 291.28 329.81
Earnings Yield
11.25% 6.30% 12.49% (2.75%) 7.68% 4.90% 5.86% 9.26% 7.50% 6.19%
Free Cash Flow Yield
9.52% 5.85% 12.43% (7.66%) 10.34% 4.87% 5.30% 6.98% 6.74% 4.80%
Revenue per Share
36.50 39.21 37.42 33.08 33.56 37.54 42.56 49.73 63.66 71.84
Operating CF per Share
14.69 10.78 17.89 (4.72) 17.10 13.32 17.64 20.90 29.36 35.24
Capex per Share
(0.87) (1.77) (4.24) (1.91) (1.29) (2.69) (3.05) (4.92) (5.45) (11.87)
Free Cash Flow per Share
13.83 9.00 13.66 (6.63) 15.81 10.63 14.59 15.97 23.91 23.37
Cash per Share
23.99 21.08 32.55 33.92 41.52 43.00 62.39 63.98 72.28 65.92
Shareholders Equity per Share
42.27 47.77 64.11 63.48 76.81 88.17 105.42 127.88 142.57 160.19
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
42.27 47.77 64.11 63.48 76.81 88.17 105.42 127.88 142.57 160.19
Free Cash Flow
605.60 396.20 594.00 (290.30) 698.80 477.40 663.70 747.60 1,080.60 1,035.20
Working Capital
1,092.30 1,003.20 1,491.40 1,401.50 1,843.90 2,018.20 3,037.10 2,746.60 3,135.80 3,141.90
Capital Expenditures
(38.00) (78.00) (184.40) (83.70) (56.90) (120.80) (138.80) (230.40) (246.50) (526.00)
Net Current Asset Value
950.50 670.30 1,155.60 731.50 947.40 1,113.40 2,132.50 2,368.80 2,953.90 2,918.70
EV/EBIT
4.95 7.68 4.74 0.00 9.98 15.87 10.87 7.04 9.50 12.71
Capex to Sales
0.02 0.05 0.11 0.06 0.04 0.07 0.07 0.10 0.09 0.17
Net Profit Margin
44.64% 24.22% 36.20% (7.21%) 34.71% 28.23% 37.56% 42.31% 41.53% 41.94%
Price to Operating Income
5.94 8.20 5.88 0.00 11.30 17.45 12.69 8.98 11.58 14.46
Other line items
Depreciation/Fixed assets
0.06 0.06 0.05 0.06 0.07 0.06 0.06 0.05 0.06 0.05
Cash ROIC
5.32% (2.18%) 1.77% (18.47%) 0.40% (2.73%) (0.70%) (0.70%) 1.05% (1.68%)
Accounts Receivable Turnover
7.85 6.74 6.89 8.86 9.61 9.47 9.24 9.32 10.31 10.11
Accounts Payable Turnover
0.70 0.77 1.18 0.75 0.64 0.68 0.75 0.98 0.96 0.92
Inventory Turnover
0.80 1.02 1.90 1.21 1.20 1.36 1.55 2.41 2.30 2.25
Average Days of Payables
523.15 590.84 305.12 460.60 631.41 520.24 553.52 422.41 406.01 463.37
Days of Inventory on Hand
502.06 372.60 185.53 289.89 292.07 279.49 245.58 158.47 186.09 173.86
Average Receivables
203.65 255.80 236.40 163.55 154.40 178.05 209.55 249.65 279.10 314.75
Average Payables
103.80 137.65 168.60 157.25 167.70 180.80 202.25 263.95 321.25 416.25
Average Inventory
90.65 103.95 104.45 97.20 89.95 90.15 97.90 106.90 134.85 170.50
Average Assets
2,255.00 2,602.50 3,140.20 3,657.20 4,264.20 4,892.05 5,606.80 6,605.75 7,265.50 7,622.00
Average Common Equity
1,719.95 1,976.55 2,445.20 2,784.50 3,087.80 3,677.05 4,377.80 5,390.75 6,214.40 6,770.10

Fold the line items

Columns are period end dates